Effect of ramipril on the incidence of diabetes [3]

New England Journal of Medicine

Volumn 356, Issue 5, 2007, Pages 522-524

  Bangalore, Sripal ^a   Messerli, Franz H ^a  

^a ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PLACEBO; RAMIPRIL; ANGIOTENSIN RECEPTOR ANTAGONIST; ROSIGLITAZONE; ANGIOTENSIN RECEPTOR;

DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DRUG EFFECT; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; INCIDENCE; INSULIN RESISTANCE; LETTER; PRIORITY JOURNAL; NOTE; DRUG ANTAGONISM; HEALTH CARE COST; MORBIDITY; MORTALITY;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BLOOD GLUCOSE; DIABETES MELLITUS; HUMANS; HYPERTENSION; INCIDENCE; INSULIN RESISTANCE; RAMIPRIL; RECEPTORS, ANGIOTENSIN;

EID: 33846683004     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc063077     Document Type: Letter

References (5)

1. The DREAM Trial Investigators. Effect of ramipril on the incidence of diabetes. N Engl J Med 2006;355:1551-62.
2. Ferrannini E, Buzzigoli G, Bonadonna R, et al. Insulin resistance in essential hypertension. N Engl J Med 1987;317:350-7.
3. Lissner L, Bengtsson C, Lapidus L, Kristjansson K, Wedel H. Fasting insulin in relation to subsequent blood pressure changes and hypertension in women. Hypertension 1992;20:797-801.
4. Taittonen L, Uhari M, Nuutinen M, Turtinen J, Pokka T, Akerblom HK. Insulin and blood pressure among healthy children: cardiovascular risk in young Finns. Am J Hypertens 1996;9:194-9.
5. Cooper-Dehoff R, Cohen JD, Bakris GL, et al. Predictors of development of diabetes mellitus in patients with coronary artery disease taking antihypertensive medications (findings from the INternational VErapamil SR-Trandolapril STudy [INVEST]). Am J Cardiol 2006;98:890-4.